Treatment of psychoses with quetiapine antipsychotic

Details for Australian Patent Application No. 2005209142 (hide)

Owner AstraZeneca AB

Inventors Brecher, Martin; Mullen, Jamie; Ault, Brian; Minkwitz, Margaret; Block, Gilbert; Wilson, Ellis; MacFadden, Wayne

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005209142

PCT Pub. Number WO2005/072742

Priority 60/540,618 30.01.04 US

Filing date 27 January 2005

Wipo publication date 11 August 2005

International Classifications

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

Event Publications

3 August 2006 PCT application entered the National Phase

  PCT publication WO2005/072742 Priority application(s): WO2005/072742

21 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005209150-Weatherable multilayer articles and method for their preparation

2005209139